PhRMA Showers Millions on Dark Money Groups Fighting Drug Price Reforms
We run down the recipients of drugmaker donations revealed in PhRMA's latest tax filing.
18 posts with this tag
PhRMA
Featured
A Corporate Lobbying Firm Is Advising the Harris Transition
Harris transition team adviser Covington & Burling works to influence the government for dozens of clients and is defending Amazon against the Federal Trade Commission.
House Dems Donate to Centrist Group That Undermines Their Agenda
House Democratic leadership groups have given more than a million dollars to the PhRMA-funded Center Forward, which has worked to undermine the Biden administration on drug pricing reforms and more.
PhRMA Funnels Millions to Groups Fighting Drug Pricing Reforms
The pharma lobby gave more than $16 million in 2022 to advocacy groups, many of them ostensibly “grassroots,” that are battling the Medicare drug price negotiations now underway.
ALEC Gala to Face Protest From Pro-Democracy Groups
The industry-funded group is celebrating 50 years with a gala in D.C.
Pharma Ally Kurt Schrader Cashes In on K Street
Schrader’s new lobbying employer works for numerous drug companies like Pfizer and Sanofi, plus industry trade association PhRMA.
Pfizer Spends Big on IP Lobbying With Billions on the Line
The pharmaceutical giant spent big bucks amid key international negotiations last year to protect record earnings.
STOCK TICKER: Blumenthal’s Wife Invests in Biotech Hedge Fund as He Chairs Panel Overseeing Drug Prices
As a consumer protection subcommittee chairman, Blumenthal has focused on the role pharmaceutical benefit managers play in driving up the cost of drugs.
Pharma Lobby Enlists Minority Groups to Fight Drug Pricing Reform
PhRMA-funded groups the National Hispanic Council on Aging and the National Minority Quality Forum say most voters of color do not support the Democrats' drug pricing reform proposal.
Senators Against Generic Covid-19 Vaccines Have Gotten 2x Pharma Cash
A group of Republican senators sought to block U.S. support for an IP waiver for Covid-19 vaccines, a proposal that is strongly opposed by the pharmaceutical industry.